The company has agreed to acquire New York-based Kinentia Biosciences, expanding its US presence and combining Kinentia’s ...

Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample ...

The UK's advertising watchdog has ruled against several companies advertising oral GLP-1 weight loss medications to the UK ...

Learn why early notified-body engagement is critical for combination products, including design rationale, risk controls, validation evidence and traceable documentation ahead of submission.

Piramal Pharma Solutions (PPS) is to invest more than $5.3m in upgrading its drug substance manufacturing site in Aurora, ...

The accelerated pathway extends the CDMO's Rapid Antibody framework to bispecifics and next-generation formats — targeting ...

The new space complements established solid-phase synthesis operations, giving Agilent's Advanced Therapeutics Division a dedicated environment to develop solvent-free enzymatic manufacturing approach ...

This new technology platform addresses stability, concentration, and delivery challenges in biologics, including new ...

At Booth 11F93 in Hall 11, the company will not only be showcasing its new look, it will also present solutions for sensitive ...

Tablet coating defects rarely begin at the coating stage. In this live webinar, industry expert Fred Rowley examines the ...

The expansion includes new fluorinated sugars and GMP-grade Poly(I:C), supporting glycoengineering, bioproduction, vaccine ...

The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's ...